Figure 1From: Optimal tumor sampling for immunostaining of biomarkers in breast carcinomaHeterogeneity of MAP-Tau expression in a whole tissue section of breast carcinoma. (a) H&E stain. (b) Immunofluorescence. Nuclei are labeled with DAPI. Cytokeratin is labeled with Cy3. MAP-Tau is labeled with Cy5.Back to article page